|
MOBKL2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.62447832963153E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.649200E-01 |
| Stage1-vs-Stage3 |
5.731000E-01 |
| Stage1-vs-Stage4 |
7.383200E-04 |
| Stage2-vs-Stage3 |
8.805800E-01 |
| Stage2-vs-Stage4 |
8.055900E-02 |
| Stage3-vs-Stage4 |
2.370000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.424140E-04 |
| Normal-vs-Asian |
1.62503344114384E-12 |
| Caucasian-vs-AfricanAmerican |
3.480400E-01 |
| Caucasian-vs-Asian |
7.473600E-01 |
| AfricanAmerican-vs-Asian |
4.344400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
7.703200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.295900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.017800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.756400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.924650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.333400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.517790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.772800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.141200E-01 |
| Classical-VS-Follicular |
5.582900E-03 |
| Classical-VS-Other |
5.325800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.255600E-02 |
| Tall-VS-Other |
5.081600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.229200E-01 |
| Follicular-VS-Normal |
2.96662694410088E-12 |
| Other-VS-Normal |
6.180400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
8.738500E-03 |
|
|
